FR941206-2-00056 FR941206-2-00042 Food and Drug Administration Advisory Committee; Renewals AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) announces the renewal of certain FDA advisory committees by the Commissioner of Food and Drugs. This notice is issued under the Federal Advisory Committee Act of October 6, 1972 (Pub. L. 92&hyph;463 (5 U.S.C. app. 2)). DATES: Authority for these committees will expire on the dates indicated below unless the Commissioner formally determines that renewal is in the public interest. 1Name of the committee 1Date of expiration Allergenic Products Advisory Committee July 9, 1996 Cardiovascular and Renal Drugs Advisory Committee August 27, 1996 Endocrinologic and Metabolic Drugs Advisory Committee August 27, 1996 Oncologic Drugs Advisory Committee September 1, 1996 Anti-Infective Drugs Advisory Committee October 7, 1996 Dermatologic and Ophthalmic Drugs Advisory Committee (Formerly Dermatologic Drugs Advisory Committee) October 7, 1996 Biological Response Modifiers Advisory Committee October 28, 1996 FOR FURTHER INFORMATION CONTACT: Donna M. Combs, Committee Management Office (HFA&hyph;306), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301&hyph;443&hyph;2765. Dated: November 29, 1994. Linda A. Suydam, Interim Deputy Commissioner for Operations. [FR Doc. 94&hyph;29989 Filed 12&hyph;5&hyph;94; 8:45 am] BILLING CODE 4160&hyph;01&hyph;F
